Talat Imran - 23 May 2025 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Chief Executive Officer, Director
Signature
Talat Imran
Issuer symbol
RANI
Transactions as of
23 May 2025
Transactions value $
$0
Form type
4
Filing time
23 May 2025, 17:58:52 UTC
Previous filing
10 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Imran Talat Chief Executive Officer, Director 2051 RINGWOOD AVE, SAN JOSE Talat Imran 23 May 2025 0001869579

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Stock Option (Right to Buy) Award $0 +1.05M $0.00 1.05M 23 May 2025 Class A Common Stock 1.05M $0.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from May 23, 2025.